NDC 38779-0454-03: Papaverine Hydrochloride 1 g/g Powder, 5 g Bottle
This is a package of 5 g of Papaverine Hydrochloride 1 g/g Powder from Medisca Inc., first listed with the FDA Jul 2014 and currently FDA-listed. It is the main listing for this product, which comes in 5 package sizes.
NDC database record
One package, one record: these facts belong to NDC 38779-0454-3 alone.
- Record
- FDA NDC Directory package listing · Bulk ingredient
- Code segments
- 38779 labeler · 0454 product · 3 package
- Package marketed since
- Jul 7, 2014
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 3877904543 5
- FDA record last changed
- Jul 24, 2026
Other active recalls for Papaverine Hydrochloride (different manufacturers) — 1 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 000528
- GCN: 02110
- GPI-14 (Medi-Span): 40100060102900
- HICL (First Databank): 000170
- AHFS class code: 24:12.92.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It relaxes smooth muscle, so it is used when spasm is part of the problem. That includes blood vessel spasm with heart attack, angina, or clots in the arteries of the limbs or lung...
- It is injected into a vein or a muscle by a healthcare professional. When it goes into a vein, it should be given slowly over 1 to 2 minutes to avoid uncomfortable side effects. Yo...
- Some people notice nausea, stomach discomfort, headache, flushing, sweating, or dizziness. Tell your care team if these bother you. Let them know right away about anything that see...
- People with complete atrioventricular heart block should not get it by vein, because it can cause abnormal heart rhythms. Make sure your care team knows your heart history.
Patient education
Drug interactions
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
| Medicare Part B allowsASP · J2440 | No ASP payment limit on file for J2440 this quarter. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Billing & reimbursement
Where does this data come from?
- CMS ASP NDC-HCPCS crosswalk · refreshed Nov 22, 2026
- DMEPDAC NDC-HCPCS crosswalk
- openFDA NSDE billing units · refreshed Nov 7, 2026
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 38779-0454-03 You're viewing this Main listing | 5 g in 1 BOTTLE, GLASS | — | — | Active |
| 38779-0454-04 38779-0454-4 | 25 g in 1 JAR | — | — | Active |
| 38779-0454-05 38779-0454-5 | 100 g in 1 JAR | — | — | Active |
| 38779-0454-08 38779-0454-8 | 500 g in 1 JAR | — | — | Active |
| 38779-0454-09 38779-0454-9 | 1000 g in 1 JAR | — | — | Active |
You're viewing the smallest of 5 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 38779-0454-04?
What NDC number is used to bill for this package of Papaverine Hydrochloride 1 g/g Powder?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Papaverine Hydrochloride 1 g/g 70859-0101-01 | NuCare | 1 g | — | — | FDA listed | — |
| Papaverine Hydrochloride 1 g/g 62991-1203-02 | LETCO | 25 g | — | — | FDA listed | — |
| Papaverine Hydrochloride 1 g/gthis 38779-0454-03 | Medisca | 5 g | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Papaverine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Medisca Inc. labeler code 38779
- Caffeine 1 g/g Powder NDC 38779-0419-5
- Chlorpromazine Hydrochloride 1 g/g Powder NDC 38779-0423-1
- Doxycycline Hyclate 1 g/g Powder NDC 38779-0434-0
- Imipramine Hydrochloride 1 g/g Powder NDC 38779-0443-3
- Loperamide Hydrochloride 1 g/g Powder NDC 38779-0446-3
- Orphenadrine Citrate 1 g/g Powder NDC 38779-0452-2
- Pramoxine Hydrochloride 1 g/g Powder NDC 38779-0458-4
- Phenylbutazone 1 g/g Powder NDC 38779-0497-3
- Cyclophosphamide 1 g/g Powder NDC 38779-0506-3
- Enalapril Maleate 1 g/g Powder NDC 38779-0514-4
- Bupivacaine Hydrochloride 1 g/g Powder NDC 38779-0524-1
- Ciprofloxacin Hydrochloride 1 g/g Powder NDC 38779-0534-5
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
This is a bulk ingredient listing — not a retail prescription package
Papaverine Hydrochloride 1 g/g POWDER is listed with FDA as a bulk ingredient (a drug substance supplied for further manufacturing or licensed pharmacy compounding). It is not a finished product a patient would receive at a retail pharmacy, so consumer-style information — a patient label, retail pricing, package photos — generally does not exist for this NDC. The listing identifies the substance and package for supply-chain and regulatory purposes.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | ✓ Available |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |